{"id":5615,"date":"2019-06-16T10:47:49","date_gmt":"2019-06-16T08:47:49","guid":{"rendered":"http:\/\/wordpress.p545550.webspaceconfig.de\/uncategorized\/wirtschaftsempfang-2019-im-izb-2\/"},"modified":"2020-07-13T15:59:14","modified_gmt":"2020-07-13T13:59:14","slug":"wirtschaftsempfang-2019-im-izb-2","status":"publish","type":"post","link":"https:\/\/www.izb-online.de\/en\/wirtschaftsempfang-2019-im-izb-2\/","title":{"rendered":"Economic reception in 2019 at the IZB"},"content":{"rendered":"

[vc_row el_class=”gco-magazine-container”][vc_column el_class=”bildspalte”][vc_row_inner][vc_column_inner offset=”vc_col-lg-12 vc_col-md-12″][vc_column_text el_class=”gco-magazine–title”]<\/p>\n

Economic reception in 2019 at the IZB<\/span><\/h1>\n

[\/vc_column_text][vc_column_text el_class=”gco-magazine–post-date”]June 2019[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”two-columns”][vc_column_inner][vc_single_image image=”5608″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription” el_id=”special-high”]Dr. Peter Hanns Zobel<\/strong>, Managing Director, Innovation- and Start-up-Center for Biotechnology (IZB), Michael Durach<\/strong>, Managing Director, Develey Senf & Feinkost GmbH, Prof. Petra Schwille<\/strong>, Director Max Planck Institute of Biochemistry, Angela Inselkammer<\/strong>, Managing Director, Ayinger Privatbrauerei, Kerstin Schreyer<\/strong>, Bavarian State Minister for Family, Labour and Social Affairs, Michael Scholl<\/strong>, CEO, Leukocare AG, Maxi\u00admilian Jell<\/strong>, Head of Regulatory Affairs & Reduced Risk Products, Philipp Morris GmbH, Franz Inselkammer<\/strong>, Managing Director, Ayinger Privatbrauerei (f.l.t.r.)[\/vc_column_text][vc_single_image image=”5602″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription” el_id=”special-high”]Dr. Wandan Solongo<\/strong>, Bayernwerk AG, Dr. Andrea Sommer<\/strong>, Rechtsanw\u00e4ltin \/ Lawyer, Dr. Stefan Arend<\/strong>, KWA Kuratorium Wohnen im Alter gAG, Uwe Wollschl\u00e4ger, Bayernwerk AG (v.l.n.r.)[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”gco-magazine-container–copy”][vc_column_inner][vc_column_text]75 entrepreneurs followed up the joint invitation of the Minister of State Kerstin Schreyer and Dr. Peter Hanns Zobel, Managing Director of the IZB. This network meeting took place for the seventh time on May 28, 2019. \u201cIt is very important that companies in the region continue to network. But I’m also pleased about everyone who is here for the first time today, because the contacts that are made here lead to synergies and new, joint projects,\u201d said Schreyer in her speech. Kerstin Schreyer also talked about her work as Minister of State for Family, Labor and Social Affairs.<\/p>\n

In her presentation, the minister focused on the subject of the skilled worker shortage: \u201cThe Bavarian State Government aims to permanently close the gap in the shortage of skilled workers. And we can only do that if we tap into all domestic as well as all intra-European potential. Because it can not be that our economy is desperately looking for skilled workers, while the know-how is lying idle on our doorstep.\u201d Schreyer described measures by which the Family, Labor and Social Affairs Ministry would like to bring more elderly people and people with disabilities into workplaces. The current debates on working hours and pensions were also a topic.<\/p>\n

Dr. Peter Hanns Zobel welcomed the minister and the 75 guests at the event. \u201cI’m pleased that so many of you took up our invitation. Every year, business relations arise at the reception that develop further,\u201d said Zobel. \u201cIn addition to manufacturing plants and trading and service companies, biotech and pharmaceutical companies are also based in the region. Cooperation between these companies and the young start-ups at the IZB leads to enormous growth potential in the district,” explained Zobel.[\/vc_column_text][vc_column_text css=”.vc_custom_1583761043671{background-color: #1e73be !important;}” el_class=”redaktionell”][\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner el_class=”two-columns” css=”.vc_custom_1594644981533{margin-bottom: 30px !important;}”][vc_column_inner][vc_single_image image=”5604″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription” el_id=”special-high”]Dr. Kai Lamottke<\/strong>, Bicoll GmbH, Prof. Andr\u00e9 Br\u00e4ndli<\/strong>,\u00a0 Biomedical Center Munich, Gundel Hager<\/strong>, Ph.D., Crelux a WuXi Apptech Company, Dr. Martin Ried<\/strong> (f.l.t.r.)[\/vc_column_text][vc_single_image image=”5606″ img_size=”full”][vc_column_text el_class=”gco-magazine-copyright”]\u00a9 IZB[\/vc_column_text][vc_column_text el_class=”gco-magazine-picture-discription” el_id=”special-high”]Dr. Roman Zantl<\/strong>, Ibidi GmbH, Dr. Michael Mai<\/strong>, Menlo Systems GmbH, Michael Scholl<\/strong>, Leukocare AG (v.l.n.r.)[\/vc_column_text][\/vc_column_inner][\/vc_row_inner]\n\n

\n \n